APTEVO THERAPEUTICS INC (APVO) Stock Cash Flow
NASDAQ:APVO - Nasdaq - US03835L3069 - Common Stock
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -24.95M | -17.41M | 8.03M | -28.46M | -17.75M | |||
| Depreciation Amortization | 436.00K | 567.00K | 901.00K | 1.14M | 1.41M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -1.58M | 2.91M | 2.14M | -2.65M | -2.41M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 1.80M | 2.20M | -32.09M | 8.29M | -10.57M | |||
| OPERATING CASH FLOW | -24.30M | -11.73M | -21.02M | -21.68M | -29.32M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -29.00K | -713.00K | -88.00K | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | 28.12M | |||
| INVESTING CASH FLOW | 0.00 | 0.00 | -29.00K | -713.00K | 28.03M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | -3.47M | -12.27M | -10.55M | 2.63M | |||
| Stock Issued/Repurchased | 11.36M | 9.47M | 6.93M | 11.44M | 21.26M | |||
| Other Financing Activity | -6.00K | -10.00K | 2.72M | 25.27M | -11.00K | |||
| FINANCING CASH FLOW | 11.36M | 6.00M | -2.62M | 26.16M | 23.87M | |||
| CHANGE IN CASH | -12.94M | -5.73M | -23.67M | 3.77M | 22.59M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -24.30M | -11.73M | -21.02M | -21.68M | -29.32M | |||
| Capital Expenditure | N/A | 0.00 | -29.00K | -713.00K | -88.00K | |||
| FREE CASH FLOW | -24.30M | -11.73M | -21.05M | -22.39M | -29.41M | |||
All data in USD